Compare Novavax Inc (NVAX) vs SYSCO Corporation (SYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs SYSCO Corporation — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while SYSCO Corporation trades at $81.33 (market cap $38.63B). The key difference: SYSCO Corporation is far larger — about 29.7× Novavax Inc's market cap, and SYSCO Corporation pays a 2.72% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | SYY | |
|---|---|---|
Market Cap | $1.30B | $38.63B |
Sector | Health | Consumer Staples |
52-Week High | $11.19 | $91.16 |
52-Week Low | $6.22 | $69.30 |
Enterprise Value | $800.50M | $52.11B |
Dividend Yield | — | 2.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →
